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Ryanodine receptors (RyRs) release Ca2+ to initiate
striated muscle contraction. Three highly divergent
regions (DRs) in the RyR protein sequence (DR1,
DR2, and DR3) may confer isoform-specific func-
tional properties to the RyRs. We used cell-based
fluorescence resonance energy transfer (FRET) mea-
surements to localize these DRs to the cryoelectron
microscopic (cryo-EM) map of the skeletal muscle
RyR isoform (RyR1). FRET donors were targeted to
RyR1 using five different FKBP12.6 variants labeled
with Alexa Fluor 488. FRET was then measured to
the FRET acceptors, Cy3NTA or Cy5NTA, targeted
to decahistidine tags introduced within the DRs.
DR2 and DR3 were localized to separate positions
within the ‘‘clamp’’ region of the RyR1 cryo-EM
map, which is presumed to interface with Cav1.1.
DR1 was localized to the ‘‘handle’’ region, near the
regulatory calmodulin-binding site on the RyR. These
localizations provide insights into the roles of DRs in
RyR allosteric regulation during excitation contrac-
tion coupling.
INTRODUCTION
In skeletal muscle excitation-contraction (EC) coupling, intracel-
lular calcium (Ca2+) stored in the sarcoplasmic reticulum (SR) is
released by the ryanodine receptor (RyR), a massive homotetra-
meric Ca2+-release channel, and this released Ca2+ then triggers
muscle cell contraction. Three mammalian RyR isoforms exist:
RyR1 and RyR2 govern EC coupling in skeletal and cardiac mus-
cle, respectively, whereas RyR3 is expressed in many tissues at
low levels (Giannini et al., 1995; Jeyakumar et al., 1998; Nakai
et al., 1990; Otsu et al., 1990; Takeshima et al., 1989; Zorzato
et al., 1990).
Although the three RyR isoforms share about 65% sequence
identity (Hakamata et al., 1992), three major regions of sequence
divergence have been identified: divergent region 2 (DR2) (RyR1
residues 1,342–1,403); DR3 (RyR1 residues 1,872–1,923); and
DR1 (RyR1 residues 4,254–4,631) (Figure 1A) (Sorrentino and1322 Structure 22, 1322–1332, September 2, 2014 ª2014 Elsevier LtVolpe, 1993). These DRs underlie functional differences between
the different RyR isoforms. DR2 has been implicated in mechan-
ical coupling between RyR1 and the voltage-dependent L-type
Ca2+ channel (Cav1.1) a1 subunit (Perez et al., 2003), which is
essential for skeletal-type EC coupling. DR3, which includes a
stretch of 30 negatively charged amino acid residues in RyR1
(Zorzato et al., 1990), has been implicated in Ca2+- and Mg2+-
dependent regulation of the RyR (Bhat et al., 1997), and may
also interact with the II-III loop of the Cav1.1 a1 subunit (Proenza
et al., 2002). Finally, DR1 is predicted to contain a large unstruc-
tured cytoplasmic loop flanked by two transmembrane (TM) seg-
ments (Otsu et al., 1990; Takeshima et al., 1989; Zorzato et al.,
1990). Mutations in DR1 alter Ca2+ and caffeine sensitivity of
RyR1 (Bhat et al., 1997; Hayek et al., 1999, 2000).
To understand the role of these regions in RyR1 function, it is
essential to determine their locations within the 3D structure of
the channel. In cryoelectron microscopic (cryo-EM) reconstruc-
tions, the RyR is composed of a large cytoplasmic domain and
a much smaller TM assembly that contains the Ca2+ channel
(Radermacher et al., 1994; Samso´ et al., 2005, 2009; Serysheva
et al., 1999; Sharma et al., 2000). The corners of the cytoplasmic
assembly are known as ‘‘clamp’’ regions, which themselves are
connected by ‘‘handles’’ (Figure 1B). Previous studies havemap-
ped these DRs to the cardiac muscle RyR (RyR2) cryo-EM map
by inserting GFP into each DR of RyR2 and then comparing the
resulting map with wild-type (WT) (Liu et al., 2002, 2004; Zhang
et al., 2003). The inserted GFPs appear as excess densities
when subtracting cryo-EM maps of WT RyR2 from GFP-RyR2,
and the locations of these densities have been assumed to
correspond to the DR locations. However, uncertainty exists
about the positions of these regions because the cryo-EM map-
ping method localizes the fused GFP, rather than its insertion
site. Significant distances may separate the fused GFP from its
insertion site (Raina et al., 2012), due to the physical dimensions
of GFP and the lengthy poly-Gly linkers often used to tether it to
the RyR. These issues may have led to discrepancies between
sequence regions localized to the cryo-EM map using protein
fusions, compared with docking of atomic structures of RyR
fragments derived from the same locations (Liu et al., 2001;
Tung et al., 2010).
In this study, we used fluorescence resonance energy transfer
(FRET)-based trilateration to localize these DR sequence ele-
ments to the RyR1 cryo-EM map. This method relies on FRET-
based distance measurements taken between small fluorescentd All rights reserved
Figure 1. Strategy for FRET-Based Localizations of His10 Tags in
RyR1 DRs
(A) FRET-based method used in this study. FKBP (green oval) acts as a FRET
donor transferring energy to Cy3NTA or Cy5NTA, FRET acceptors that bind
specifically to His10 tags inserted into either DR2 (blue), DR3 (pink), or DR1
(yellow) within the RyR1 protein sequence (black bar).
(B) Cryo-EM reconstruction of RyR1 as viewed from the ‘‘top’’ (i.e., the side
facing the t-tubule membrane in situ) showing the clamp and handle regions,
key subdomains within the clamp region (numbered), and FKBP (yellow
structure; FK) docked to each RyR1 subunit.
(C) Ribbon diagram of FKBP in same orientation as ‘‘FK’’ atomic structure in
(B), indicating numbered AF488-labeled amino acid positions (red spheres)
and optimized AF488 donor position (green spheres).
(D) Sequence positions of each of the DRs within RyR1 and the locations of the
inserted His10 tags.
Structure
FRET-Based Trilateration of RyR1 Divergent Regionsprobes targeted to specific sites on RyR1 using donor-labeled
variants of the FK506-binding protein (FKBP) and small FRET ac-
ceptors targeted to decahistidine (His10) ‘‘tags.’’ Our results map
these DRs to different RyR1 surface locations, where they may
play diverse roles in channel function, including mediating EC
coupling and interacting with RyR-associated proteins.RESULTS
Experimental Strategy
We employed a cell-based FRET approach to localize the RyR1
DRs to the RyR1 cryo-EM map (Figure 1A). We targeted FRET
donors to RyR1 using fluorescent variants of FKBP (12.6 kDa
isoform), which bind with nanomolar affinity between the RyR1
clamp and handle regions, far from its 4-fold axis of symmetry
(Figure 1B) (Cornea et al., 2010; Samso´ et al., 2006). A set of
five fluorescent donor-labeled FKBPs (D-FKBPs) was producedStructure 22, 1322–13via covalent attachment of Alexa Fluor 488 (AF488) to each of five
engineered cysteine substitutions at well-distributed FKBP12.6
surface positions (Figure 1C) (Girgenrath et al., 2013). The loca-
tions of these AF488 donors relative to their attachment sites in
FKBP12.6 were determined from simulated annealing calcula-
tions (Figure 1C, green spheres). In human embryonic kidney
293T (HEK293T) cells, we targeted these D-FKBPs to separate
RyR1 constructs that each contained a His10 tag inserted into
one of the three RyR1 DRs (Figure 1D). We then measured
FRET from each of these five donor-labeled positions to two
different FRET acceptors (Cy3 nitrilotriacetic acid [NTA] and
Cy5NTA) that bind to these His10 tags but have different distance
sensitivities (defined by the Fo¨rster distance, R0, at which 50%
FRET occurs), resulting from differing spectral overlaps with
AF488 (Figure S1 available online). Distances calculated from
these dual FRET measurements were then used to identify loci
corresponding to the position of Cy3NTA or Cy5NTA relative to
FKBP docked to its known location on the RyR1 cryo-EM map
(Cornea et al., 2010; Samso´ et al., 2006). FRET measurements
from GFP fusions within RyR1 to Cy3NTA targeted to these
His10 tags were used to further constrain the trilateration results
obtained using D-FKBPs. The His10-tagged positions within the
RyR1 cryo-EM map were then determined from surfaces on the
RyR1 cryo-EM map closest to the acceptor locus that satisfied
all constraints.
R0 for the AF488-Cy5NTA Donor-Acceptor Pair
Previously (Girgenrath et al., 2013), we used the AF488/Cy3NTA
donor-acceptor pair to trilaterate multiple positions within the
RyR1 ‘‘ABC’’ domain, the N-terminal atomic structure that has
been docked to the RyR1 cryo-EM map (Tung et al., 2010).
From spectral overlap (Figure S1), we had calculated a theoret-
ical R0 of 66 A˚ for this donor-acceptor pair. However, not all fac-
tors affecting R0 are measurable, so we corrected this R0 for our
experimental system using FRET measurements between fixed
reference points on the docked FKBP12 and ABC domain.
From these fixed points, we derived an optimized R0 of 59 A˚
for AF488/Cy3NTA that resulted in trilaterations of ABC domain
positions that colocalized well with the actual His10 insertion
sites in the ABC domain. In the current study, we performed a
similar optimization of the AF488/Cy5NTA R0 value by trilaterat-
ing a His10 tag placed at position 500 (Figure 2), within the ‘‘C’’
domain spanning amino acid residues 393–559 (Tung et al.,
2010).
D-FKBP bound specifically to HEK293T cells expressing the
His500-RyR1 construct (Figure 2A), which released Ca2+ in
response to caffeine with a similar EC50 as WT RyR1 (Figure 2B).
FRETmeasured from each of the five D-FKBP donor positions to
Cy3NTA targeted to His500 ranged from 0.18 (for D14-FKBP) to
0.63 (for D32-FKBP) (Figure 2C), whereas FRET to Cy5NTA
was lower from each donor position (as expected based on
lower spectral overlap; Figure S1). However, the pattern of
FRET efficiencies using these two acceptors was remarkably
similar (Figure 2C). Using an R0 of 53 A˚ for AF488/Cy5NTA to
derive donor-acceptor distances from each of the five D-FKBP
positions to Cy5NTA bound to His500-RyR1, we trilaterated a
locus only 20 A˚ from residue 500 (Figures 2D and 2E). Using
the Cy3NTA-derived FRET data and an R0 of 59 A˚ we previously
determined for the AF488/Cy3NTA FRET pair, we trilaterated a32, September 2, 2014 ª2014 Elsevier Ltd All rights reserved 1323
Figure 2. Optimization of AF488/Cy5NTA R0
Using Trilateration of His500-RyR1 Construct
(A) Characterization of D14-FKBP binding to
His500-RyR1. Panels show AF488 D14-FKBP flu-
orescence (upper left), His500-RyR1 expression
(upper right), and overlay (lower left) for HEK293T
cells expressing His500-RyR1 treated with 10 nM
D14-FKBP followed by anti-RyR immunocyto-
chemistry. No significant difference in FKBP
binding to His500-RyR1 was observed, relative to
WT RyR1 (lower-right panel).
(B) Functional analysis of His500-RyR1. Concentra-
tion dependence of caffeine-induced Ca2+ release
from either WT RyR1 or His500-RyR1 is shown.
(C) FRET analysis of His500-RyR1. FRET efficiency
values are shown from each of five labeled FKBP
positions to Cy3NTA (red) or Cy5NTA (blue) after
each FRET acceptor was targeted to HEK293T
cells expressing His500-RyR1. Values represent
mean ± SEM.
(D and E) Trilateration of Cy3/5NTA bound to His500
within the cryo-EM map (gray). Loci determined
using either the Cy3NTA (red) or Cy5NTA data set
(blue) are depicted relative to FKBP (yellow, with
numbered red dots indicating attachment sites of
AF488 donors) and the insertion site of theHis10 tag
(green sphere) within the RyR1 ‘‘C’’ domain (purple
ribbonstructure) docked to theRyR1cryo-EMmap.
See also Figure S1.
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FRET-Based Trilateration of RyR1 Divergent Regionssecond locus 25 A˚ from the His10 tag insertion site and 7.5 A˚ from
the locus derived from the Cy5NTA-based FRET data (Figures
2D and 2E). These experiments and analysis validated an R0 of
53 A˚ for the AF488/Cy5NTA pair, which we then used in parallel
trilaterations of the RyR1 DRs (see below). These experiments
also provided an estimate of the accuracy of our trilateration
method, which is affected by the linker between the acceptor
fluorophore and its NTA moiety, and on the His10 insert. Taken
together, these factors may offset the acceptor probe by up to
25 A˚ from the His10 tag insertion site, as we observed for the
His500-RyR1 construct. These constraints were used to map
the His tag insertions in the RyR1 DRs (see below).
Analysis of FKBPBinding toConstructs Containing His10
Tags in the RyR1 DRs
FKBP12.6with AF488 conjugated to amino acid residue 14 (D14-
FKBP) bound specifically to HEK293T cells expressingWT RyR1
because D-FKBP fluorescence colocalized with RyR1 detected
by immunofluorescence (Figure 3A). D14-FKBP also bound to
RyR1 containing His10 tags at position 1358(DR2), 1915(DR3),
or 4429(DR1) (Figure 3A), at levels statistically unchanged
compared to WT RyR1 (Figure 3B). In contrast, D-FKBP binding
to RyR1 containing a His10 tag at position 1863(DR3) was essen-
tially undetectable (Figures 3A and 3B).
Functional Analysis of His10-Tagged RyR1 Proteins
All His10-tagged RyR1 constructs released Ca
2+ in response to
caffeine, an RyR agonist (Figure 4A). EC50 values for caffeine
activation of these constructs were statistically unchanged
compared to WT RyR1 (Figures 4B and 4C), thus indicating
that the His10 insertions did not significantly affect RyR1 caffeine
sensitivity. The His10-tagged construct at position 1863 also1324 Structure 22, 1322–1332, September 2, 2014 ª2014 Elsevier Ltreleased Ca2+ in response to caffeine as reported previously
(Fessenden, 2009).
FRET Analysis of His10-Tagged RyR1 Proteins
FRET efficiencies were measured from D-FKBP to Cy3NTA or
Cy5NTA targeted to His10 tags inserted at positions 1358(DR2),
1915(DR3), or 4429(DR1). To ensure full occupancy of the
acceptor-binding site (His10 tags) with the Cy3/5NTA probes,
we determined the binding affinity of each FRET acceptor for
each His10-RyR1 construct (Figure S2). The FRET dependence
on [Cy3NTA] was saturable for each His10-RyR construct, with
EC50 values ranging from 0.12 to 0.43 mM (Figure S2A). The
FRET dependence on [Cy5NTA] was also saturable, with EC50
values between 0.41 and 0.61 mM (Figure S2B). From these
curves, binding saturation at 3 mM Cy3/5NTA (used for subse-
quent FRET-based distancemeasurements) was used to correct
the measured FRET values for trilaterations, as needed.
We next measured FRET from each of the five D-FKBP variants
to 3 mMCy3/5NTAFRET acceptors targeted to eachHis10 tag. For
Cy3NTA targeted to His10 at RyR1 position 1358 (in DR2), FRET
efficiencies (E) ranged from 0.27 for D44-FKBP as donor to 0.43
for D32-FKBP as donor, thus suggesting that these FKBP-
attached probes were furthest and closest, respectively, to DR2
(Figure 5A). In contrast, FRET efficiencies to Cy3NTA targeted to
DR3 were very different compared to DR2, ranging from 0.17 for
D85-FKBP to 0.58 for D44-FKBP (Figure 5B). Finally, E for
Cy3NTA targeted to a His10 tag inserted at RyR1 position 4429
(in DR1) showed relatively little variation, ranging from 0.16 for
D32-FKBP to 0.27 for D49-FKBP (Figure 5C). Thus, the profiles
of FRET efficiencies between FKBP and each of these His10 inser-
tion siteswere completely distinct from each other, which suggest
that these sites are in different parts of the RyR1 cryo-EM map.d All rights reserved
Figure 3. FKBP Binding to RyR1 Constructs
with His10 Tags in the DRs
(A) HEK293T cells expressing WT, His1358(DR2),
His1863(DR3), His1915(DR3), or His4429(DR1) RyR1
constructs are shown after incubation with 10 nM
D14-FKBP (left panels) and subsequent analysis
of RyR1 expression using immunocytochemistry
(middle panels). Right panels indicate overlay of
the two channels.
(B) D-FKBP-binding maximum (Bmax) of indicated
His10-tagged RyR construct normalized to WT
RyR1 level. The number of cells analyzed is indi-
cated for each construct. Values representmean ±
SEM. Significance (*) was determined by one-way
ANOVA, followed by Dunnett’s posttest (p < 0.01).
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FRET-Based Trilateration of RyR1 Divergent RegionsWe performed a parallel series of FRET measurements using
Cy5NTA (Figure 5, blue bars). In all cases, FRET efficiencies
measured with Cy5NTA were lower compared to equivalent
measurements with Cy3NTA (Figure 5, red bars), a result
consistent with the shorter R0 for the AF488-Cy5NTA pair.
However, the profile of FRET efficiencies measured using these
two FRET acceptors was the same to each His10-tagged posi-
tion. This finding supports the conclusion that the observed
FRET efficiencies are related to the distances between probes
and, thus, are unlikely to be biased by anisotropic acceptor
dynamics.
FRET between GFP and Cy3NTA Bound to RyR1
His10 Tags
To further constrain trilaterations using D-FKBPs as donors, we
measured FRET from GFP fused at RyR1 position 1 (GFP(1)) or
620 (GFP(620)) to Cy3NTA bound to each of the DR His10 tags
(Figure 6A). Because we have previously localized these GFP
fusions to the RyR1 cryo-EM map (Raina et al., 2012), we usedStructure 22, 1322–1332, September 2, 2014 ªthese FRET measurements as additional
constraints to localize acceptors bound
to the DRs. All GFP/His10-tagged RyR1constructs were functional, without significant changes in EC50
values for caffeine activation, compared with WT RyR1 (Fig-
ure S3). No significant energy transfer was detected from GFP
at position 1 to any of the His10 positions in the DRs (Figure 6B),
thus suggesting that the GFP donor fused to the RyR1 N termi-
nus is beyond detection range by FRET to the His10 tags inserted
in the DRs. In contrast, we did measure significant energy trans-
fer from GFP(620) to Cy3NTA targeted to DR2 (at position 1358)
and both sites within DR3 (positions 1863 and 1915), which had
mean FRET efficiencies of 0.22, 0.10, and 0.13, respectively (Fig-
ure 6B). No significant energy transfer was detected from
GFP(620) to Cy3NTA targeted to DR1 (position 4429).
Trilateration of DR2
Using these measured FRET values, the position of each His10
tag within the cryo-EM map was determined via trilateration.
For His1358 (DR2) (Figure 7), no locus could be identified that
satisfied FRET measurements from all five D-FKBP donors.
However, several possible loci were identified from data setsFigure 4. Functional Analysis of RyR1 Con-
structs with His10 Tags in the DRs
(A) Representative Fluo-4-based Ca2+ imaging
traces are shown for WT RyR1 and each His10-
tagged construct. Indicated caffeine concentra-
tions were perfused during the time intervals
indicated (black bars). Calibration is 0.5 F/F0 ratio
units versus 1 min.
(B) Concentration dependence of normalized
caffeine-induced Ca2+ release in HEK293T cells
expressing each RyR1 construct. Values repre-
sent mean ± SEM.
(C) Summary of EC50 values, 95% confidence in-
tervals (C.I.), and number of cells analyzed (n) for
caffeine activation of each His10-tagged con-
struct. No significant differences were observed
between these EC50 values as determined by one-
way ANOVA, followed by Dunnett’s posttest (p <
0.05).
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Figure 5. FRET Measurements from FKBP-
Attached Donors to Acceptors Targeted to
His10 Tags in the RyR1 DRs
FRET efficiency values are shown from each of five
labeled D-FKBP positions to 3 mM Cy3NTA (red
bars) or Cy5NTA (blue) targeted to HEK293T cells
expressing His1358 (DR2) (A), His1915 (DR3) (B), or
His4429 (DR1) (C)RyR1constructs.Values represent
mean ± SEM. See also Figure S2 and Table S1.
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FRET-Based Trilateration of RyR1 Divergent Regionsderived from combinations of four FKBP donors (Figure 7A). Our
hypothesis was that one of these loci represented the location of
Cy3NTA bound to His1358 in DR2. To identify the most likely
candidate, we assessed the distance of each of these loci from
the surface of the RyR1 cryo-EM map. From the trilateration of
His500-RyR1 (Figures 2D and 2E), we estimated the distance
from the His10 tag insertion site to the FRET-derived locus repre-
senting Cy3NTA bound to this position to be no greater than
25 A˚. We then reasoned that candidate loci farther than 25 A˚
from the RyR1 surface could not represent viable locations of
the triangulated Cy3NTA and could thus be excluded; in this
case, loci lacking the distances derived from the D14- or D44-
FKBP-based FRET data, denoted D14a and D44a, respec-
tively (Figures 7A and 7B).
We refined these trilaterations using FRET measurements
from GFP(1) and GFP(620) to DR2 (Figures 7B and 7C). Because
no FRET was detected from GFP(1) to Cy3NTA bound to His1358
(Figure 6B), we ruled out loci within 90 A˚ of the fused GFP
(150% of the GFP/Cy3NTA R0 of 63 A˚; Girgenrath et al.,
2013). This constraint allowed us to eliminate the D14b and
D44b loci predicted to be 33 and 53 A˚ from GFP(1) (Figure 7B).
This left the D32 locus as the sole candidate for the DR2 trilat-
eration. We used FRET measured from GFP(620) as a positive
constraint to verify that this locus was acceptable. TheD32 re-
gion was within 54 A˚ of GFP(620) (Figure 7C), a distance that
should result in detectable FRET between these two positions
using these probes, which we did observe (E = 0.22, Figure 6B).
Thus, the D32 locus represents the likely position of Cy3NTA
bound to His1358 in DR2. The cyan-colored zone in Figure 7C rep-
resents the portion of the RyR1 cryo-EM map within 15 A˚ of this
locus and, thus, the likely location of the DR2 His1358 tag. An in-
dependent trilateration using FRET data obtained with Cy5NTA
as acceptor yielded a similar result (Figure 7D).
Trilateration of DR3
We used a similar process to localize position 1915 (DR3) within
the RyR1 cryo-EM map (Figure 8). In this case, trilateration
yielded a single locus that satisfied all five distances measured
from FKBP (Figure 8A). This candidate locus was 110 A˚ from
GFP(1) (Figure 8B), a distance too long to result in detectable
FRET, whichwe did not observe (Figure 6B). The candidate locus
was 62 A˚ from GFP(620), a distance compatible with our
measured FRET (E = 0.13) (Figure 6B). The surface of the RyR11326 Structure 22, 1322–1332, September 2, 2014 ª2014 Elsevier Ltd All rights reservedcryo-EM map within 15 A˚ of this locus
was located within subdomain 9, which
represents the likely position of His1915
within DR3 (Figure 8C). Distances calcu-
lated from FRET measurements obtainedusing the Cy5NTA acceptor yielded a similar trilateration result
(Figure 8C).
Trilateration of DR1
For DR1 position 4429 (Figure 9), no region in space matched
distances from all five donor positions. However, several
possible loci were identified from data sets derived from combi-
nations of four FKBP donor positions (Figure 9). These loci were
refined using the scheme outlined for DR2, which also took into
consideration the distance of each locus from the RyR1 TM as-
sembly because the DR1 His10 tag is located in a cytoplasmic
loop between two confirmed TM helices (Figure S4). From these
constraints, the locus that excluded the distance from D49-
FKBP (D49 in Figure 9) represented the most likely location
of Cy3NTA bound to the DR1 His10 (Figure 9A). This locus was
proximal to the TM assembly and also outside our detection
range for FRET from GFP(1) and GFP(620) (Figure 9B), which
we did not observe (Figure 6B). From this locus, we identified a
patch in subdomain 3 on the RyR1 cryo-EM map that repre-
sented the potential location of the His10 insertion at position
4429 (Figure 9C). An independent trilateration of this site using
Cy5NTA as acceptor yielded a similar result (Figure 9C).
DISCUSSION
FRET Method
Using distances derived from in-cell FRET measurements, we
have localized each of the three RyR1 DRs, which are thought
to confer isoform-specific functional properties to RyRs. In
important previous studies, 3D locations of these sites had
been assigned to the RyR2 cryo-EM map from densities corre-
sponding to GFP moieties inserted in each DR (Liu et al., 2004;
Zhang et al., 2003). The FRET-based method we used to localize
the DRs within the RyR1 cryo-EM map has several distinct
advantages over these methods based on GFP inserts.
FKBP12.6, used to target the FRET donor to the RyR, is a phys-
iological RyR-associated protein whose binding location and
orientation are well defined and conserved between RyR1 and
RyR2 (Cornea et al., 2010), whereas Cy3NTA and Cy5NTA, the
FRET acceptors, bind to small His10 tags inserted in the RyR1
sequence. Thus, minimal alterations of the native RyR structure
are required for these FRET measurements. At the core of our
protocol is the geometrical method termed ‘‘trilateration’’ to
Figure 6. FRET Measurements from GFP Insertions in RyR1 to
Acceptors Targeted to His10 Tags in the RyR1 DRs
(A) Strategy for FRET-based measurements from GFP fused at either the N
terminus (GFP(1)) or position 620 (GFP(620)) (green ovals) to Cy3NTA (red
rectangle) targeted to His10 tags inserted in each DR in the RyR1 protein
sequence (black bar).
(B) FRET efficiency levels are shown for GFP(1)-RyR1 or GFP(620)-RyR1 fusion
constructs lacking (His) or containing His10 tags at either the N terminus
(N-term) or positions 620, 1358 (DR2), 1863 (DR3), 1915 (DR3), or 4429 (DR1).
Values represent mean ± SEM. Asterisks indicate significant differences in
FRET relative to non-His-tagged constructs, determined using one-way
ANOVA followed by Dunnett’s posttest (p < 0.01).
See also Figure S3.
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FRET-Based Trilateration of RyR1 Divergent Regionsdetermine the relative location of a site by measuring distances
from several well-distributed donor coordinates on FKBP, which
we have defined using molecular modeling and simulated an-
nealing (Svensson et al., 2014). These optimizations of donor po-
sitions on FKBP, combined with the well-established binding
location and orientation of FKBP on RyR1 (Cornea et al., 2009,
2010; Samso´ et al., 2006), provided the best available accuracy
and precision for these trilaterations.
To localize the RyR1 DRs, we used two different FRET accep-
tors (Cy3NTA and Cy5NTA) with differing distance sensitivity
ranges when paired with the AF488 donor. We obtained over-
lapping trilateration loci with these two donor-acceptor pairs
(Figures 7D, 8C, and 9C). Consistency between measurements
using different probes indicated that the FRET-derived distances
are accurate. This implies that FRET is insignificantly affected by
probe orientation, probably because donors and acceptors un-
dergo isotropic dynamics that are fast relative to the donor fluo-
rescence lifetime (several nanoseconds) (Svensson et al., 2014).
This approach will be expanded in future studies to localize other
His-tagged positions in the proximity of RyR-bound D-FKBP
donor.
Trilateration of His10 Tags Inserted in the DRs
Our trilateration results indicate that each DR is located in a
different part of the RyR1 cryo-EM map (Figure 10A). For
example, we localized position 1358 within DR2 to domain 5 ofStructure 22, 1322–13the clamp region (Figure 7D). This location is approximately
58 A˚ from several previous cryo-EM-based localizations of this
region within subdomain 6 (Figure 10B) (Liu et al., 2004; Mur-
ayama and Kurebayashi, 2011; Sharma et al., 2000). These prior
localizations are over 100 A˚ from the donor probe location in
each of our D-FKBP variants, distances that should result in un-
detectable FRET using our system. Thus, the difference between
our FRET-based determination of this position and prior cryo-
EM-based results is quite striking. One possible reason for this
difference could be underlying local conformational dynamics
at the DR2 His10 tag insertion site. This site is glycine rich and
thus could be highly flexible. The effective location of Cy3NTA
acceptor bound to this site is near subdomain 5, but flexibility
within the loop containing the His10 tag insertion may result in
a ‘‘flopped over’’ conformation extending from the subdomain
6 location identified in previous cryo-EM studies. Such flexibility
could impart special properties to this region, such as an ability
to couple with and transfer conformational signals originating
from the Cav1.1 channel complex during EC coupling, as has
been suggested by functional studies (Perez et al., 2003; Tarroni
et al., 1997). Indeed, our DR2 localization in subdomain 5 faces
the t-tubule membrane, where it could form molecular contacts
with Cav1.1, which has been docked to the RyR1 cryo-EM map
in this location (Figure 10B) (Wolf et al., 2003). The conforma-
tional dynamics of the DR2 site may best be probed in future
studies using fluorescence lifetime-based FRET measurements,
which could be used to quantify distance distributions between
labeled sites in this region (Li et al., 2012; Muretta et al., 2013).
Our FRET-based trilateration of His1915 in DR3 localized this
region to subdomain 9 of RyR1 (Figures 10A and 10C). This
finding is entirely consistent with prior localization of this region
using GFP fused at equivalent residue 1908 of RyR2 and subse-
quent difference density mapping to low-resolution cryo-EM
structures (Liu et al., 2002, 2004; Zhang et al., 2003) (Figure 10C).
DR3 has been implicated both in weak interactions with the II-III
loop of Cav1.1 (Proenza et al., 2002) and in mediating the inhibi-
tion of RyR1 by magnesium (Bhat et al., 1997; Hayek et al., 1999,
2000). Because RyR1 activation during EC coupling is thought to
occur via relievingmagnesium inhibition (Lamb and Stephenson,
1991), the underlying conformational changes could be occur-
ring within domain 9, a notion supported by observation of
conformational changes in the clamp domain using cryo-EM (Or-
lova et al., 1996; Serysheva et al., 1999) Thus, a structural hy-
pothesis consistent with our localizations of these DRs is that
DR2 in RyR1 subdomain 5 transmits conformational changes
that occur during EC coupling to DR3 in subdomain 9 to relieve
magnesium inhibition of RyR1. Subsequent downstream confor-
mational changes then occur, resulting ultimately in channel
opening.
D-FKBP did not bind to His1863(DR3)RyR1. This region (resi-
dues 1,835–1,870 in RyR1) has been implicated as a potential
FKBP12.6-binding site in RyR2 (Zhang et al., 2003). Thus, one
possible interpretation of our findings is that the His10 insertion
at position 1863 lies at the FKBP:RyR1 interface where it blocks
fluorescent FK506-binding protein 12.6 kDa (F-FKBP) binding. If
this is the case, then a polyacidic region containing over 30 nega-
tively charged residues that is unique to RyR1 (residues 1,873–
1,920) may lie between the bound FKBP and our localization of
position 1915 on the RyR1 cryo-EM maps. We have indicated32, September 2, 2014 ª2014 Elsevier Ltd All rights reserved 1327
Figure 7. FRET-Based Trilateration of
His1358 in RyR1 DR2
(A) Side view of RyR1 cryo-EM map (gray) indi-
cating the position of FKBP12.6 (yellow, with
numbered red dots indicating attachment sites of
AF488 donors) docked to one subunit. Loci based
on sets of four distances are shown lacking mea-
surements from FKBP positions D14 (D14; dark
blue), D32 (D32; red), or D44 (D44; cyan). Note
that D14b and D44b are inside the RyR1 cryo-
EM map, which is rendered partially transparent.
(B) RyR1 cryo-EM map from the boxed region in
(A) is shown indicating distances from the D14b
and D44b loci to GFP fused to the N terminus of
RyR1 (GFP(1); green ribbon diagram). Distances
from the D14a and D44a loci to the surface of
the RyR are indicated.
(C) Inset indicates distances from either GFP(1) or
GFP(620) of RyR1 to the D32 locus (red). The
RyR1 cryo-EM map surface within 15 A˚ of this
locus is shaded (cyan).
(D) The D32 loci based on FRET measurements
to either Cy3NTA (red) or Cy5NTA (blue) are indi-
cated. The RyR1 cryo-EMmap surface within 15 A˚
of the Cy3NTA-derived locus (cyan) is within RyR1
subdomain 5.
Structure
FRET-Based Trilateration of RyR1 Divergent Regionsa possible placement of the polyacidic region in Figure 10C (or-
ange patch).
Our FRET-based trilaterations suggest that the His10 tag at po-
sition 4429 in DR1 is located in subdomain 3 of the handle region
within the RyR1 cryo-EM map. This result is consistent with pre-
vious cryo-EM localizations of this region using either GFP fusion
at equivalent residue 4,413 in RyR2 (Liu et al., 2002) or polyclonal
antibodies raised to amino acids 4,425–4,621 of RyR1 (Benac-
quista et al., 2000) (Figure 10D). Taken together, the results
from these studies suggest that DR1 comprises cytosolic
domain 3, although DR1 may extend into the TM assembly.
From the RyR1 cryo-EMmap, domain 3 appears to form a direct
structural link with the TM assembly of the RyR1 pore (Rader-
macher et al., 1994), suggesting that these domains couple TM
and cytoplasmic assemblies during channel activation. This is
also suggested by cryo-EM localizations indicating that both
physiological and pathophysiological RyR1 modulators, such
as calmodulin and Imperatoxin A, bind to RyR1 within the cleft
between domains 3 and 7 adjacent to DR1 (Samso´ et al.,
1999; Wagenknecht et al., 1997; Wagenknecht and Samso´,
2002). Indeed, our localization of DR1 overlaps with previous
cryo-EM localizations of apo-CaM in RyR1 and RyR2 (Samso´
and Wagenknecht, 2002; Huang et al., 2012). A second line of
evidence provides additional support for the role of DR1 in
modulating RyR1 activity, including potential roles in Ca2+ acti-
vation and inactivation of RyR1 as well as caffeine activation
(Bhat et al., 1997; Du et al., 2000; Hayek et al., 1999, 2000).
Perspective
In conclusion, we have used FRET-based trilateration to localize
the RyR DRs to the RyR1 3D map. This technique can theoreti-
cally be used to localize any RyR sequence site that is exposed
to the cytosol and, thus, has the potential to resolve the location
of many other physiologically relevant primary structure ele-
ments in the cryo-EM map of RyR1. In the future, we intend to1328 Structure 22, 1322–1332, September 2, 2014 ª2014 Elsevier Ltuse this method to resolve dynamic structural changes within
the DRs in response to physiological regulation, in order to
gain additional insights into their specific roles in RyR1 channel
function.EXPERIMENTAL PROCEDURES
RyR1 cDNA Cloning and Expression
cDNAs encoding full-length His10-tagged rabbit RyR1 within the pCi-Neo
mammalian expression vector (Promega) were created as follows. The cDNA
encodingHis500-RyR1was initially generatedwithin a RyR1 subclone spanning
amino acid positions 1–1645 of rabbit RyR1 created using the NheI restriction
site in the pCi mammalian expression vector and the naturally occurring AgeI
site within the RyR1 cDNA (at position 4936). DR2 (amino acid position 1358)
or DR3 (positions 1863 and 1915) His10 tag insertions were initially generated
within a RyR1 subclone spanning amino acid positions 1645–2776 of rabbit
RyR1, created using the naturally occurring unique RyR1 restriction sites,
AgeI (cDNA position 4936) and BsiWI (cDNA position 8328). The cDNA encod-
ing a His10 tag inserted into DR1 (amino acid position 4429) was initially gener-
ated within a RyR1 subclone encoding the C-terminal portion of the protein
(amino acids 4,386–5,037) created using a naturally occurring SphI site
(cDNA position 13147) and an XbaI site within the cloning vector that lies
beyond the RyR1 stop codon. Oligonucleotide primers used for mutagenesis
each contained the His10 tag coding sequence 5
0-CAC-CAT-CAC-CAT-CAC-
CAT-CAC-CAT-CAC-CAT-30, followed by either NcoI (for the His500 insertion),
EcoRV (for DR3 or DR1His10 tag insertions) or NdeI (for theDR2His10 tag inser-
tion) restriction sites to track successful clones. His10 tag encoding sites were
inserted using primer extension-driven mutagenesis using the Pfusion high-fi-
delity DNA polymerase (New England Biolabs), and the proper sequence and
reading frame were confirmed using bidirectional DNA sequencing.
HEK293T cells were grown and transiently transfected with cDNAs encod-
ing these His10-tagged RyR1 constructs using polyethylenimine as described
(Fessenden, 2009). Cells were used in functional or FRET-based assays 2 days
after transfection.
Preparation of FRET Donors and Acceptors
Fluorescent derivatives of FKBP12.6 were prepared as previously described
(Cornea et al., 2009, 2010; Girgenrath et al., 2013). Cy3NTA and Cy5NTA
were synthesized and purified as described (Fessenden, 2009).d All rights reserved
Figure 8. FRET-Based Trilateration of His1915 in RyR1 DR3
(A) Side view of the RyR1 cryo-EM map (gray) indicating the trilateration
result of Cy3NTA bound to a His10 tag at position 1915 (red), and the map
portion within 15 A˚ of this locus (DR3; pink). FKBP is docked to one RyR1
subunit as indicated (yellow, with red dots indicating attachment sites of
AF488 donors).
(B) Distances from either GFP fused at the RyR1 N terminus (GFP(1)) or
position 620 (GFP(620)) to the Cy3NTA-His1915 locus are shown.
(C) Trilateration results using either Cy3NTA (red) or Cy5NTA (blue) as ac-
ceptors are shown. Both data sets identify His1915 within RyR1 subdomain 9.
Figure 9. FRET-Based Trilateration of His4429 in RyR1 DR1
(A) Side view of the RyR1 cryo-EMmap (gray) indicating the trilateration results
of Cy3NTA bound to His10 at position 4429 in DR1. The trilateration locus (red)
was defined from data sets lacking the D49 FRET results (D49). The portion
of the RyR1 cryo-EM map within 15 A˚ of this locus is indicated in yellow.
(B) Distances from either GFP fused at the RyR1 N terminus (GFP(1)) or
position 620 (GFP(620)) to the His4429 (DR1) locus are shown.
(C) Trilateration results using either Cy3NTA (red) or Cy5NTA (blue) as
acceptors are shown. Both data sets identify His4429 within RyR1 subdomain 3.
See also Figure S4.
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HEK293T cells expressing each His10-tagged RyR construct were permea-
bilized using 0.1% saponin in FRET buffer (125 mM NaCl, 5 mM KCl,
25 mM HEPES, and 6 mM glucose [pH 7.6]). Then, 10 nM F-FKBP and
3 mM Cy3NTA or Cy5NTA were added to the cells and incubated for 60–
120 min at 37C before imaging. FRET was then measured using epifluor-
escence microscopy. Transfected HEK293T cells expressing each RyR1
construct were illuminated with a 300 W xenon lamp housed within a
Lambda DG-4 light source (Sutter Instruments), and donor fluorescence
was observed using a YFP cube set (480/30 nm band-pass excitation filter,
a 505 nm dichroic mirror, and a 535/40 nm band-pass emission filter;
Chroma Technology). Cell fluorescence was measured with a Stanford
Photonics XR-Mega 10 CCD camera (Stanford Photonics) as a series of
60 16-bit 672 3 516 pixel images across a z stack 60 mm in thickness.
Donor fluorescence was then reacquired after photobleaching the Cy3NTA
acceptor for 4 min at maximum light output using a ReAsH cube set (570/
20 nm excitation, 585 nm dichroic, and 620/60 nm emission; Chroma Tech-
nology). Cy5NTA acceptor was photobleached using a 665/30 nm excitation
filter and a 700 nm dichroic mirror (Chroma Technology). FRET was calcu-
lated usingStructure 22, 1322–13E = 1 ðFPrebleach

FpostbleachÞ; (Equation 1)
where E represents the FRET efficiency, and Fprebleach and Fpostbleach indicate
donor fluorescence intensities before and after acceptor photobleaching,
respectively. Fluorescence from background-corrected images was quanti-
fied using ImageJ version 1.45 m (NIH).
Distance Calculations
FRET efficiencies were converted to intramolecular distances using
R=R0ðð1=EÞ-1Þ1=6; (Equation 2)
where R represents the donor/acceptor distance, R0 represents the Fo¨rster
distance for the donor/acceptor pair (Girgenrath et al., 2013), and E represents
the measured FRET efficiency. R0 values were 59 and 53 A˚ for the AF488/
Cy3NTA and AF488/Cy5NTA pairs, respectively (see Results). Distances
used for trilaterations are given in Table S1.
Determination of AF488 Donor Positions Conjugated to FKBP12.6
F-FKBP donor positions were determined computationally using a modifica-
tion of a previously reported simulated annealing protocol (Svensson et al.,32, September 2, 2014 ª2014 Elsevier Ltd All rights reserved 1329
Figure 10. RyR1 DRs Localize to Different
Positions in the RyR1 Cryo-EM Map, Sug-
gesting Distinct Functional Roles
(A) Summary of trilateration results to either DR2
(cyan patch), DR3 (magenta) or DR1 (yellow).
Docking of FKBP to the RyR1 cryo-EM structure
(yellow, with numbered red dots indicating
attachment sites of AF488 donors) and locations of
RyR1 subdomains 3, 5, 6, 9, and 10 are indicated.
(B) Stepwise rotated view of RyR1 cryo-EM
structure is shown with a putative location of the
Cav1.1 cryo-EM structure (tan). The distance from
our DR2 trilateration result (cyan) to GFP fused at
position 1350 from a previously published study
(green ball) (Liu et al., 2004) is indicated.
(C) The DR3 trilateration result (magenta) is shown
relative to a GFP fusion at position 1908 (green
ball) (Zhang et al., 2003). We propose a location of
the RyR1 polyacidic sequence spanning residues
1,873–1,920 as indicated (orange).
(D) DR1 trilateration result (yellow patch) relative
to GFP fused at position 4413 (green ball) (Liu
et al., 2002) and Ca2+-calmodulin (blue ball) (Wa-
genknecht and Samso´, 2002) are indicated.
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FRET-Based Trilateration of RyR1 Divergent Regions2014; Vrljic et al., 2010) Using Discovery Studio Visualizer (Accelrys), AF488
was attached to each of five cysteines substituted into positions 14, 32, 44,
49, and 85 of the FKBP12 atomic structure docked to RyR1. We then used a
simulated annealing protocol (Bru¨nger et al., 1990) starting with a cycle of
six torsion-angle dynamics steps at 300,000 K, followed by cooling at a rate
of 500 K per cycle and a 0.75 fs integration time. The fluorescent probe, the
cysteine sulfur site of attachment, and the side chains of two to six neighboring
residues of FKBP were free to move while everything else in the model was
fixed. Themovement of the AF488 probe was constrained by the atomic struc-
ture of FKBP12 as well as local electron density from the RyR1 cryo-EM map.
These simulations produced 10,800 possible conformations of AF488 bound
to each location. The average probe location was used for trilaterations.
Trilateration
The optimized AF488 donor locations determined from our simulated anneal-
ing protocol for each of the five FKBP attachment sites (14, 32, 44, 49, and 85),
and distances calculated from our measured FRET values (Table S1), were
used to determine a locus in space corresponding to the position of each
FRET acceptor bound to each of the inserted His10 tags. The atomic structure
of FKBP12.6 with its attached FRET donors was docked to the RyR1 cryo-EM
map in the closed conformation (EMD ID #1607) (Samso´ et al., 2009). Trilater-
ation was performed as described (Girgenrath et al., 2013). Briefly, spheres
were created around each of the FKBP12.6 donor positions with radii equiva-
lent to FRET-derived distances (Table S1), and thickness was arbitrarily
assigned as 20% of the measured FRET-based distance. Then pairwise inter-
sections of each of these spheres were identified as rings corresponding to
spatial volumes derived from distances from two of the FKBP12.6 donor posi-
tions. Then intersections of each of these rings were identified, corresponding
to loci derived from four of the five FRET-based distances. Finally, each of
these loci was paired with the remaining sphere derived from the fifth FRET-
based distance, resulting in the final locus corresponding to distances from
all five donor positions. These loci were visualized as volumes using UCSF
Chimera build 39231, and distance measurements to these volumes were
taken from dummy atoms placed on their surfaces using Chimera.
FKBP/RyR1 Colocalization
Relative D-FKBP binding to each His10-tagged RyR1 construct was deter-
mined by comparing D-FKBP fluorescence intensity to the expression level
of each construct using anti-RyR immunocytochemistry. HEK293T cells ex-
pressing His10-tagged constructs were loaded with 10 nM D14-AF488 FKBP
for 60–120 min as described above (see FRET Imaging). After washing three1330 Structure 22, 1322–1332, September 2, 2014 ª2014 Elsevier Lttimes with PBS, cells were fixed in 0.5% formalin for 30 min. After washing
and a 30 min blocking in 2.5% normal goat serum and 0.1% saponin, cells
were treated 30 min with 34C anti-RyR monoclonal antibody (Developmental
Studies Hybridoma Bank) (Airey et al., 1990) diluted 1:200, followed by a
30 min incubation in rhodamine-conjugated goat anti-mouse secondary
antibody (Sigma-Aldrich) diluted 1:2,000. Fluorescence visualized at 603
magnification using either YFP (for D-FKBP) or ReAsH (for RyR1 immunocyto-
chemistry) cube sets was quantified from 60-image stacks acquired under
identical conditions, using ImageJ. The ratio of D-FKBP fluorescence to
RyR1 immunofluorescence was normalized to the corresponding ratio derived
from cells expressing WT RyR1.
Ca2+ Imaging
Transfected HEK293T cells were loaded for 30 min at 37C with 5 mM Fluo-4/
AM in Ca2+ imaging buffer containing 150 mM NaCl, 5 mM KCl, 1.2 mM
MgSO4, 25 mM HEPES, 6 mM glucose, and 2 mM CaCl2. Cells were perfused
with a graded series of caffeine concentrations in Ca2+ imaging buffer, and
changes in intracellular Ca2+ were recorded as changes in Fluo-4 fluorescence
intensity at 510 nm when the cells were excited at 480 nm. Normalized Ca2+
transients were quantified as described (Fessenden, 2009), and the data
plotted as a function of caffeine concentration were fit to a sigmoidal dose-
response function (variable slope) to determine EC50 values.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and one table and can be found with this article online at http://
dx.doi.org/10.1016/j.str.2014.07.003.
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